Better Sleep Study for Depression in Adolescents
This study, called the Better Sleep Study, is looking at whether improving sleep patterns can help teenagers aged 12 to 18 who have depression and a sleep problem called Delayed Sleep Phase (when your body's internal clock is out of sync with your wake-up time). It's testing two behavioral interventions: TranS-C (Transdiagnostic Sleep and Circadian Intervention), which is a type of sleep therapy, and Psychoeducation, which provides information on how sleep, stress, and mood are connected. The study aims to see if these interventions can improve depression symptoms and better align your biological clock with your wake-up time. The study plans to enroll 200 participants, but its current status is unclear.
- Study design
- This interventional study plans to enroll 200 participants aged 12 to 18 years old. The phase of the study is not specified.
- What's involved
- Participants will receive behavioral interventions over approximately 2 months. Assessments will be done at the beginning, end of treatment (2 months), and at 8 and 14 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for changes in depression and sleep patterns at 8 and 14 months after the start of treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Better Sleep Study
At a glance
Conditions
NCT06139861
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Children's Hospital Los Angeles
Los Angeles, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Lauren M Asarnow, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital Los Angeles
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- Change in phase angle difference (PAD) between DLMO and waketime (PADDLMO WAKETIME )baseline to end of treatment (0 and 2 months)
Validated biological and behavioral assessment; range between 0 and 11 hours, with shorter numbers indicating worse alignment between circadian biology and behavior
- Change in Children's Depression Rating Scale (CDRS-R)baseline to end of treatment (anticipated average exposure 2 months), months 8 and 14
Validated clinician administered depression symptom severity scale; range between 17 and 133, with higher numbers indicative of greater depression severity